These inhibitory effects of DOX on the TLR4/LPS-signaling pathway, including the reduction of the pro-inflammatory cytokines IL-1β and IL-6, could explain the improvement of endothelial dysfunction and diminishing of blood pressure. The gene discussed is TLR4; the disease is endothelial dysfunction.